Company intelligence / Profile preview

NeuWave Medical

Madison, Wisconsin, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

NeuWave Medical was a medical device company that developed and commercialized the Certus 140 Microwave Ablation System, a minimally invasive device using microwave energy to ablate cancerous and benign soft tissue lesions in organs like the liver, kidneys, and lungs. The minimally invasive approach reduced recovery time significantly. At the time of acquisition, its products were being used in over half of the top cancer centers in the United States, and the company employed 30 people.

Therapeutic areas: OncologyRheumatology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on NeuWave Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuWave Medical.

Explore the full profile